[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Pages 11452-11453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04273]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Research Projects in Cancer Systems Biology (CSBC Research 
Projects) (U01).
    Date: March 31, 2022.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W234, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Adriana Stoica, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, 7W234, Rockville, Maryland 20850, 240-276-6368, 
<a href="/cdn-cgi/l/email-protection#8bd8ffe4e2e8eaeab9cbe6eae2e7a5e5e2e3a5ece4fd"><span class="__cf_email__" data-cfemail="bdeec9d2d4dedcdc8ffdd0dcd4d193d3d4d593dad2cb">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-1 NCI Clinical and Translational R21 and Omnibus R03 
Review.
    Date: March 31, 2022.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room 7W602, Rockville, Maryland 20850 (Telephone 
Conference Call).
    Contact Person: Delia Tang, M.D., Scientific Review Officer, 
Resources Training and Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W602, Rockville, Maryland 20850, 240-276-6456, 
<a href="/cdn-cgi/l/email-protection#483c29262f2c082529212466262120662f273e"><span class="__cf_email__" data-cfemail="a4d0c5cac3c0e4c9c5cdc88acacdcc8ac3cbd2">[email protected]</span></a>.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Social and Behavioral Intervention Research to Address 
Modifiable Risk Factors for Cancer in Rural Populations (R01).
    Date: May 5, 2022.
    Time: 10:00 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute at Shady Grove, 9609 Medical 
Center Drive, Room

[[Page 11453]]

7W618, Rockville, Maryland 20850 (Telephone Conference Call).
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
9609 Medical Center Drive, Room 7W618, National Cancer Institute, 
NIH, Rockville, Maryland 20850, 240-276-6611, <a href="/cdn-cgi/l/email-protection#fe938b959b8d96d0958b939f8ccdbe909796d0999188"><span class="__cf_email__" data-cfemail="701d051b1503185e1b051d110243301e19185e171f06">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 24, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-04273 Filed 2-28-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>